In his weekly clinical update, Dr. Griffin discusses variant specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on omicron VOC, ventilation in buildings, COVID-19 mortality among selective serotonin reuptake inhibitor users, risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses, trajectories of the evolution of post COVID-19 condition, and efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19.
Click arrow to play
Download TWiV 1008 (19 MB .mp3, 32 min)
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Virus variant clinical performance of a SARS-CoV-2 rapid antigen test (CID) 2:18
- Ventilation in buildings (CDC) 4:53
- COVID-19 mortality among SSRI users (CMI) 8:21
- Risk of post-acute sequelae of SARS-CoV-2 infection associated with sleep apnea (SLEEP) 12:20
- Trajectories of the evolution of post COVID-19 condition (IJID) 14:30
- Efficacy of cognitive behavioral therapy targeting fatigue following COVID-19 (CAD) 17:18
- Contribute to our FIMRC fundraiser at PWB 21:25
- Letters read on TWiV 1008 22:34
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
Leave a Reply